The Czech Republic Annual Report 2010 Drug ... - Drogy-info.cz

More documents

Recommendations

Info

elation to the sale of drugs (mainly cannabinoids and methamphetamine) in the border areas (Národní protidrogová centrála SKPV Policie ČR, 2011b); see also the chapter on Drug Markets (p. 131). The information collected by means of an e-mail and telephone survey on drug tourism conducted by the National Focal Point among low-threshold programmes for drug users (drop-in centres and outreach programmes) in August 2011 indicates that Slovaks are the foreign nationals who most commonly maintain contact with such services. Russian-speaking clients comprise a relatively large client group too. As reported by one of Prague’s drop-in centres, there has been a year-on-year rise in the number of foreigners seeking their services, and there is a clear demand for substitution, detoxification, and long-term psychiatric and psychotherapeutic treatment. As far as the availability of the services is concerned, the absence of health insurance among foreigners indicated for a specific type of treatment intervention poses a problem. The outreach programmes that were interviewed added that Prague, or sometimes also Karlovy Vary, is the main destination (Národní monitorovací středisko pro drogy a drogové závislosti, 2011f). On the basis of a question aimed at this specific item of information, it was found that foreigners made up 1,011 out of 12,720 individuals (7.9%) treated at the Prague sobering-up station in the Na Bulovce University Hospital in 2010. page 161
LIST OF TABLES Table 1-1: Overview of regional and municipal coordination instruments in 2010...............................................................15 Table 1-2: Drug policy expenditures from the Czech state budget in 2002–2010 by ministries/departments (€ thousand) 18 Table 1-3: Drug policy expenditures from Czech regional budgets in 2002–2010 (€ thousand) .........................................19 Table 1-4: Drug policy expenditures from state and local budgets in 2002–2010 (€ thousand) ..........................................20 Table 1-5: Comparison of expenditures provided from public budgets by service category from 2007 to 2010..................20 Table 1-6: Income of providers of drug policy programmes subsidised by the GCDPC in 2006–2010 (by source) ............21 Table 1-7: 2010 drug policy expenditures from state and local budgets by location (region) of use (€ thousand) ..............22 Table 1-8: 2010 drug policy expenditures in the Czech Republic by service categories (€ thousand) ................................23 Table 1-9: Costs incurred by health insurers in relation to the F11–F19 diagnoses according to the type of health facility in 2007–2009 (€ thousand) .........................................................................................................................................26 Table 1-10: Costs incurred by health insurers in relation to the F11–F19 diagnoses according to the type of specialisation in 2007–2009 (€ thousand) .........................................................................................................................................27 Table 2-1: Prevalence rates of use of of selected illicit drugs drugs recorded by the 2010 Citizen Survey, in %................29 Table 2-2: Prevalence rates of use of of selected licit and illicit drugs drugs recorded by the 2000 survey Selected Aspects of the Drug Problem from Citizens’ Perspective, in % ...................................................................................30 Table 2-3: CAST scale results – levels of risk (probability of cannabis-related problems) among current cannabis users, in % .............................................................................................................................................................................32 Table 2-4: M-CIDI scale results, in %..................................................................................................................................32 Table 2-5: Prevalence rates of use of selected legal and illegal drugs among the general population of internet users aged 15–34, in % ........................................................................................................................................................33 Table 2-6: Prevalence rates of use of selected legal and illegal drugs among internet users aged 15–34 who had used new synthetic drugs (legal highs), in % .......................................................................................................................34 Table 2-7: Prevalence of use of cannabis among 15-year-old elementary school students as recorded by the 2010 HBSC 2010 survey, in %........................................................................................................................................................38 Table 2-8: 2010 Safer Party clients’ reported prevalence of drug use, in %........................................................................40 Table 3-1: Universal and selective prevention projects delivered within the school setting; supported by GCDPC subsidies in 2010 ........................................................................................................................................................43 Table 4-1: Mean values of prevalence estimates of problem drug use carried out using the multiplication method with the use of data from low-threshold programmes in 2002–2010 ........................................................................................49 Table 4-2: Prevalence estimates of problem drug users in the Czech Republic in 2010 by region – mean values.............50 Table 4-3: Estimates of problem drug use carried out using the multiplication method with the use of data from lowthreshold programmes by region in 2005–2010, mean values....................................................................................51 Table 4-4: Prevalence estimates of problem drug users obtained from questionnaire surveys among general practitioners in 2003, 2005, 2007, and 2010....................................................................................................................................52 Table 4-5: The estimated number of people aged 15–64 in the Czech Republic in 2008 who had used the drug at least once a week in the last month.....................................................................................................................................53 Table 4-6: The estimated prevalence of hazardous patterns of alcohol use in the general population of the Czech Republic aged 18–64, in % .........................................................................................................................................54 Table 5-1: Treatment programmes providing services to drug users in the Czech Republic in 2010..................................57 Table 5-2: Overview of certified programmes by type as of 16 May 2011...........................................................................58 Table 5-3: Number of outpatient healthcare facilities and number of addictive substance users treated in 2000–2010 .....59 Table 5-4: Number of outpatient healthcare facilities according to number of addictive substance, alcohol, and drug users treated in 2006–2010 ..................................................................................................................................................59 Table 5-5: Number of addictive substance users (including alcohol and tobacco users) treated in outpatient healthcare facilities in 2006–2010.................................................................................................................................................59 Table 5-6: Number of outpatient healthcare facilities according to number of addictive substance users treated and facility locations in 2010 ..............................................................................................................................................60 Table 5-7: Imported (methadone) and distributed (buprenorphine) quantities of substitution drugs in 1999–2010............61 Table 5-8: Number of healthcare facilities actively reporting clients to the Substitution Treatment Register, by region, 2000–2010 ..................................................................................................................................................................62 Table 5-9: Number of registered healthcare facilities in the NRULISL electronic application, 2007–2010 ..........................62 Table 5-10: Physicians providing substitution treatment and the number of patients in substitution treatment in the 2010 survey of Czech physicians.........................................................................................................................................63 Table 5-11: Estimate of the number of patients in opiate substitution treatment provided by general practitioners for children and adolescents in 2010................................................................................................................................64 Table 5-12: Registration in NRULISL and patient reporting to NRULISL in the 2010 survey of Czech physicians .............64 Table 5-13: Outpatient treatment facilities operated by NGOs and client numbers in 2003–2010 ......................................66 Table 5-14: Network of inpatient facilities providing the detoxification of alcohol/drug-using patients and numbers of dedicated beds in detoxification units in 2010 .............................................................................................................68 Table 5-15: Number of psychiatric inpatient facilities, total bed capacity, and occupancy by users of drugs other than alcohol (excluding tobacco) in 2000–2010 ..................................................................................................................69 Table 5-16: Educational facilities for young people in institutional care, protective custody, or preventive care in the Czech Republic in 2009–2010 ....................................................................................................................................70 Table 5-17: Capacity and number of children with drug use problems in specialised departments of educational facilities providing institutional, protective, and preventive care in the Czech Republic in 2009–2010......................................70 Table 5-18: Trends in the number of addictive substance users in treatment at outpatient healthcare facilities in 1993– 2010 according to addictive substance groups ...........................................................................................................77 page 162
Page 1:
Annual Report The Czech Republic 20
Page 5 and 6:
Annual Report: The Czech Republic -
Page 7 and 8:
PART B: SELECTED ISSUES............
Page 9 and 10:
In 2010 the very first representati
Page 11 and 12:
In the Czech Republic, the treatmen
Page 13 and 14:
PART A: NEW DEVELOPMENTS AND TRENDS
Page 15 and 16:
ange applies to addictologists who
Page 17 and 18:
Republic has been reporting the hig
Page 19 and 20:
Wenceslas Square and in the surroun
Page 21 and 22:
Regions of the Czech Republic to ca
Page 23 and 24:
Region Pardubice Vysočina South Mo
Page 25 and 26:
educe drug supply (particularly to
Page 27 and 28:
Map 1-1: 2010 drug policy expenditu
Page 29 and 30:
Total state budget Regions Table 1-
Page 31 and 32:
1.3.2 Drug Treatment Costs Incurred
Page 33 and 34:
Table 1-9: Costs incurred by health
Page 35 and 36:
2 Drug Use in the General Populatio
Page 37 and 38:
Table 2-2: Prevalence rates of use
Page 39 and 40:
The M-CIDI questionnaire, containin
Page 41 and 42:
Table 2-6: Prevalence rates of use
Page 43 and 44:
Figure 2-2: Attitudes towards crimi
Page 45 and 46:
Table 2-7: Prevalence of use of can
Page 47 and 48:
Table 2-8: 2010 Safer Party clients
Page 49 and 50:
school curriculum and school rules;
Page 51 and 52:
partly also by regional public heal
Page 53 and 54:
3.4 Indicated prevention Indicated
Page 55 and 56:
4 Problem Drug Use The EMCDDA defin
Page 57 and 58:
Table 4-2: Prevalence estimates of
Page 59 and 60:
Table 4-4: Prevalence estimates of
Page 61 and 62:
The general population studies (see
Page 63 and 64:
Information on treatment and counse
Page 65 and 66:
5.2.1 Professional Competency of Se
Page 67 and 68:
Table 5-6: Number of outpatient hea
Page 69 and 70:
Table 5-8: Number of healthcare fac
Page 71 and 72:
The proportions found for prescribi
Page 73 and 74:
Map 5-2: Sobering-up station networ
Page 75 and 76:
Table 5-14: Network of inpatient fa
Page 77 and 78:
care centres report to diagnostic i
Page 79 and 80:
cannabis, especially among adolesce
Page 81 and 82:
Map 5-4: Number of all treatment de
Page 83 and 84:
Figure 5-8: Selected characteristic
Page 85 and 86:
5.3.3.2 Clients in Opiate Substitut
Page 87 and 88:
Figure 5-10: Trends in the capacity
Page 89 and 90:
Table 5-23: Number of hospitalisati
Page 91 and 92:
Table 6-1: Number of newly detected
Page 93 and 94:
Figure 6-5: Reported incidence of s
Page 95 and 96:
The monitoring of testing for infec
Page 97 and 98:
Table 6-8: Results of testing for H
Page 99 and 100:
Table 6-9: Sharing of needles and s
Page 101 and 102:
tests for cannabis; see Table 6-12.
Page 103 and 104:
Pervitin was the cause of a fatal o
Page 105 and 106:
Table 6-15: Deaths with the presenc
Page 107 and 108:
Table 6-17: Fatal drug overdoses in
Page 109 and 110:
Figure 6-13: Comparison of trends i
Page 111 and 112:
7 Responses to Health Correlates an
Page 113 and 114:
Table 7-2: Selected services of low
Page 115 and 116:
Map 7-2: Number of needles and syri
Page 117 and 118: Table 7-8: History of HBV, HCV, and
Page 119 and 120: 8 Social Correlates and Social Rein
Page 121 and 122: Altogether, 987 clients (610 of the
Page 123 and 124: 9 Drug-Related Crime, Prevention of
Page 125 and 126: Table 9-2: Number of persons arrest
Page 127 and 128: Figure 9-1: Total number of persons
Page 129 and 130: Table 9-7: Sentences and other meas
Page 131 and 132: Table 9-9: Drug-related misdemeanou
Page 133 and 134: in custody, and 8 being the inmates
Page 135 and 136: (approximately 0.5%). However, only
Page 137 and 138: Table 9-15: NGOs providing drug ser
Page 139 and 140: Supported by the National Focal Poi
Page 141 and 142: was rather bizarre. For example, th
Page 143 and 144: shut down by the authorities. The l
Page 145 and 146: the regional police headquarters on
Page 147 and 148: conduct research in the area of pen
Page 149 and 150: Republic for the Period 2011-2012 f
Page 151 and 152: departments) or by the external pro
Page 153 and 154: more than 10 clients, etc. This is
Page 155 and 156: 12 Drug Users with Children The aim
Page 157 and 158: Childbirth and the National Registe
Page 159 and 160: Table 12-2: Total number of mothers
Page 161 and 162: (diagnostic institutions), and reha
Page 163 and 164: 12.3.2 Helping Services Help to chi
Page 165 and 166: 13 Cross-border Travel, Drug Use, a
Page 167: ethnic minorities in the Czech Repu
Page 171 and 172: Table 9-10: Criminal offences commi
Page 173 and 174: SELECTED DRUG-RELATED WEB PAGES ON
Page 175 and 176: 2005-2009 National Strategy - Natio
Page 177 and 178: ministry, 18, 41, 42, 115 ministry
Page 179 and 180: Generální ředitelství Vězeňsk
Page 181 and 182: Mravčík, V., Zábranský, T., Kor
Page 183 and 184: Policie ČR (2011) Statistické př
Page 185 and 186: Van den Berg, C., Smit, C., Van Bru
show all

The Czech Republic Annual Report 2010 Drug ... - Drogy-info.cz

Create successful ePaper yourself

Delete template?

Save as template?